| UniProt ID | NOC3L_HUMAN | |
|---|---|---|
| UniProt AC | Q8WTT2 | |
| Protein Name | Nucleolar complex protein 3 homolog | |
| Gene Name | NOC3L | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 800 | |
| Subcellular Localization | Nucleus, nucleolus. Nucleus speckle. | |
| Protein Description | May be required for adipogenesis.. | |
| Protein Sequence | MKARRNKKQIPSFRKLIKTSKVKLENKLKNKQFKQQSTLKKYRKEQRKLRQAVKDAVSKKPIPLENPKEKRPGKRIEREEEEEEEALPLDMMDEDDLQLMKDLGQRVSFLTRDLSSSEPVHAKKRKHERIIDKYEKIPRTLQTAPEKELIHLLPIKDKSGIIPQTREKPVTDSNKDEEDQEEERELEEEIIEDPIQELTIEEHLIERKKKLQEKKMHIAALASAILSDPENNIKKLKELRSMLMEQDPDVAVTVRKLVIVSLMELFKDITPSYKIRPLTEAEKSTKTRKETQKLREFEEGLVSQYKFYLENLEQMVKDWKQRKLKKSNVVSLKAYKGLAEVAVKSLCELLVALPHFNFHNNIIVLIVPLMNDMSKLISEMCCEAVKKLFKQDKLGQASLGVIKVISGFVKGRNYEVRPEMLKTFLCLRIKEVEVKKDTEDINKPKKFMTFKEKRKSLSRMQRKWKKAEEKLERELREAEASESTEKKLKLHTETLNIVFVTYFRILKKAQRSPLLPAVLEGLAKFAHLINVEFFDDLLVVLHTLIESGDLSYQESLHCVQTAFHILSGQGDVLNIDPLKFYTHLYKTLFKLHAGATNEGVEIVLQCLDVMLTKRRKQVSQQRALAFIKRLCTLALHVLPNSSIGILATTRILMHTFPKTDLLLDSESQGSGVFLPELDEPEYCNAQNTALWELHALRRHYHPIVQRFAAHLIAGAPSEGSGALKPELSRRSATELFEAYSMAEMTFNPPVESSNPKIKGKFLQGDSFLNEDLNQLIKRYSSEVATESPLDFTKYLKTSLH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 23 | Acetylation | LIKTSKVKLENKLKN HHHHCHHHHHHHHCC | 54.54 | 133323 | |
| 34 | Acetylation | KLKNKQFKQQSTLKK HHCCCHHHHHHHHHH | 44.96 | 133325 | |
| 37 | Phosphorylation | NKQFKQQSTLKKYRK CCHHHHHHHHHHHHH | 32.96 | 30108239 | |
| 38 | Phosphorylation | KQFKQQSTLKKYRKE CHHHHHHHHHHHHHH | 37.95 | 30108239 | |
| 40 | Acetylation | FKQQSTLKKYRKEQR HHHHHHHHHHHHHHH | 48.09 | 133321 | |
| 59 | Ubiquitination | AVKDAVSKKPIPLEN HHHHHHHCCCCCCCC | 56.84 | 21890473 | |
| 78 | Ubiquitination | RPGKRIEREEEEEEE CCCCCCCCCHHHHHH | 55.01 | 24816145 | |
| 108 | Phosphorylation | KDLGQRVSFLTRDLS HHHHHHHHHHHCCCC | 19.41 | 25159151 | |
| 115 | Phosphorylation | SFLTRDLSSSEPVHA HHHHCCCCCCCCCCC | 35.79 | 25159151 | |
| 116 | Phosphorylation | FLTRDLSSSEPVHAK HHHCCCCCCCCCCCC | 46.12 | 25159151 | |
| 117 | Phosphorylation | LTRDLSSSEPVHAKK HHCCCCCCCCCCCCH | 42.41 | 25159151 | |
| 123 | Acetylation | SSEPVHAKKRKHERI CCCCCCCCHHHHHHH | 37.93 | 25953088 | |
| 123 | 2-Hydroxyisobutyrylation | SSEPVHAKKRKHERI CCCCCCCCHHHHHHH | 37.93 | - | |
| 124 | Acetylation | SEPVHAKKRKHERII CCCCCCCHHHHHHHH | 68.42 | 25953088 | |
| 133 | Acetylation | KHERIIDKYEKIPRT HHHHHHHHHHHCCCC | 44.92 | 26051181 | |
| 134 | Phosphorylation | HERIIDKYEKIPRTL HHHHHHHHHHCCCCC | 20.78 | - | |
| 147 | Acetylation | TLQTAPEKELIHLLP CCCCCCHHHHEEEEE | 57.68 | 25953088 | |
| 159 | Phosphorylation | LLPIKDKSGIIPQTR EEECCCCCCCCCCCC | 45.41 | - | |
| 171 | Phosphorylation | QTREKPVTDSNKDEE CCCCCCCCCCCCCHH | 42.09 | 19691289 | |
| 173 | Phosphorylation | REKPVTDSNKDEEDQ CCCCCCCCCCCHHHH | 36.09 | 19691289 | |
| 195 | Ubiquitination | EEIIEDPIQELTIEE HHHHHCHHHHCCHHH | 8.43 | 27667366 | |
| 223 | Phosphorylation | MHIAALASAILSDPE HHHHHHHHHHHCCCC | 19.38 | 20068231 | |
| 227 | Phosphorylation | ALASAILSDPENNIK HHHHHHHCCCCCHHH | 45.03 | 20068231 | |
| 241 | Phosphorylation | KKLKELRSMLMEQDP HHHHHHHHHHHHCCC | 28.97 | 20068231 | |
| 253 | Phosphorylation | QDPDVAVTVRKLVIV CCCCHHHHHHHHHHH | 12.59 | 20068231 | |
| 261 | Phosphorylation | VRKLVIVSLMELFKD HHHHHHHHHHHHHCC | 15.75 | 24670416 | |
| 273 | Phosphorylation | FKDITPSYKIRPLTE HCCCCCCCCCCCCCH | 16.19 | - | |
| 274 | Ubiquitination | KDITPSYKIRPLTEA CCCCCCCCCCCCCHH | 36.25 | 22817900 | |
| 284 | Phosphorylation | PLTEAEKSTKTRKET CCCHHHHHCCCHHHH | 27.00 | 26074081 | |
| 285 | Phosphorylation | LTEAEKSTKTRKETQ CCHHHHHCCCHHHHH | 47.72 | 26074081 | |
| 287 | Phosphorylation | EAEKSTKTRKETQKL HHHHHCCCHHHHHHH | 47.24 | 26074081 | |
| 293 | Ubiquitination | KTRKETQKLREFEEG CCHHHHHHHHHHHHH | 57.86 | 24816145 | |
| 333 | Acetylation | KSNVVSLKAYKGLAE CCCCCCHHHHCCHHH | 42.01 | 25953088 | |
| 333 | Sumoylation | KSNVVSLKAYKGLAE CCCCCCHHHHCCHHH | 42.01 | 28112733 | |
| 386 | Acetylation | EMCCEAVKKLFKQDK HHHHHHHHHHHHCCC | 51.29 | 25953088 | |
| 390 | Acetylation | EAVKKLFKQDKLGQA HHHHHHHHCCCCCCH | 68.94 | 26051181 | |
| 398 | Phosphorylation | QDKLGQASLGVIKVI CCCCCCHHHHHHHHH | 20.12 | 20068231 | |
| 410 | Ubiquitination | KVISGFVKGRNYEVR HHHHCCCCCCCCCCC | 50.30 | 27667366 | |
| 410 | Acetylation | KVISGFVKGRNYEVR HHHHCCCCCCCCCCC | 50.30 | 26051181 | |
| 422 | Acetylation | EVRPEMLKTFLCLRI CCCHHHHHHHHHHHC | 35.60 | 26051181 | |
| 430 | Acetylation | TFLCLRIKEVEVKKD HHHHHHCCEEEECCC | 49.64 | 26051181 | |
| 443 | Acetylation | KDTEDINKPKKFMTF CCCCCCCCCCCCCCH | 59.56 | 26051181 | |
| 445 | 2-Hydroxyisobutyrylation | TEDINKPKKFMTFKE CCCCCCCCCCCCHHH | 61.32 | - | |
| 449 | Phosphorylation | NKPKKFMTFKEKRKS CCCCCCCCHHHHHHH | 34.39 | 28555341 | |
| 456 | Phosphorylation | TFKEKRKSLSRMQRK CHHHHHHHHHHHHHH | 35.29 | 24719451 | |
| 481 | Phosphorylation | ELREAEASESTEKKL HHHHHHHCHHHHHHH | 24.48 | 20068231 | |
| 483 | Phosphorylation | REAEASESTEKKLKL HHHHHCHHHHHHHHH | 39.09 | 20068231 | |
| 484 | Phosphorylation | EAEASESTEKKLKLH HHHHCHHHHHHHHHH | 48.01 | 20068231 | |
| 492 | Phosphorylation | EKKLKLHTETLNIVF HHHHHHHHHHHHHHH | 40.89 | - | |
| 494 | Phosphorylation | KLKLHTETLNIVFVT HHHHHHHHHHHHHHH | 26.68 | - | |
| 567 | Phosphorylation | QTAFHILSGQGDVLN HHHHHHHCCCCCCCC | 28.59 | 24719451 | |
| 628 | Sumoylation | QRALAFIKRLCTLAL HHHHHHHHHHHHHHH | 32.63 | - | |
| 628 | 2-Hydroxyisobutyrylation | QRALAFIKRLCTLAL HHHHHHHHHHHHHHH | 32.63 | - | |
| 628 | Sumoylation | QRALAFIKRLCTLAL HHHHHHHHHHHHHHH | 32.63 | - | |
| 717 | Phosphorylation | HLIAGAPSEGSGALK HHHHCCCCCCCCCCC | 54.80 | 20068231 | |
| 720 | Phosphorylation | AGAPSEGSGALKPEL HCCCCCCCCCCCHHH | 19.48 | 20068231 | |
| 724 | Acetylation | SEGSGALKPELSRRS CCCCCCCCHHHHHHC | 35.59 | 26051181 | |
| 728 | Phosphorylation | GALKPELSRRSATEL CCCCHHHHHHCHHHH | 24.80 | 20068231 | |
| 760 | Acetylation | SNPKIKGKFLQGDSF CCCCCCCCCCCCCCC | 37.59 | 25953088 | |
| 760 | Ubiquitination | SNPKIKGKFLQGDSF CCCCCCCCCCCCCCC | 37.59 | 29967540 | |
| 777 | Ubiquitination | EDLNQLIKRYSSEVA HHHHHHHHHHCHHCC | 54.60 | 29967540 | |
| 779 | Phosphorylation | LNQLIKRYSSEVATE HHHHHHHHCHHCCCC | 16.14 | 23663014 | |
| 780 | Phosphorylation | NQLIKRYSSEVATES HHHHHHHCHHCCCCC | 24.85 | 23663014 | |
| 781 | Phosphorylation | QLIKRYSSEVATESP HHHHHHCHHCCCCCC | 27.44 | 23663014 | |
| 785 | Phosphorylation | RYSSEVATESPLDFT HHCHHCCCCCCCHHH | 42.02 | 30266825 | |
| 787 | Phosphorylation | SSEVATESPLDFTKY CHHCCCCCCCHHHHH | 26.80 | 23927012 | |
| 792 | Phosphorylation | TESPLDFTKYLKTSL CCCCCHHHHHHHHCC | 20.60 | 23663014 | |
| 793 | Ubiquitination | ESPLDFTKYLKTSLH CCCCHHHHHHHHCCC | 48.88 | 29967540 | |
| 793 | Acetylation | ESPLDFTKYLKTSLH CCCCHHHHHHHHCCC | 48.88 | 26051181 | |
| 794 | Phosphorylation | SPLDFTKYLKTSLH- CCCHHHHHHHHCCC- | 15.46 | 23663014 | |
| 796 | Ubiquitination | LDFTKYLKTSLH--- CHHHHHHHHCCC--- | 32.74 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NOC3L_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NOC3L_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NOC3L_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DDX24_HUMAN | DDX24 | physical | 26344197 | |
| PESC_HUMAN | PES1 | physical | 26344197 | |
| RL4_HUMAN | RPL4 | physical | 26344197 | |
| RLA0_HUMAN | RPLP0 | physical | 26344197 | |
| RRP12_HUMAN | RRP12 | physical | 26344197 | |
| SRP72_HUMAN | SRP72 | physical | 26344197 | |
| TBL3_HUMAN | TBL3 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-787, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-787, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115 AND SER-117, ANDMASS SPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-787, AND MASSSPECTROMETRY. | |